Table 1.
Thirty-day, 12-month, and lifetime prevalence estimates of DSM-IV/CIDI MDE by age and gender
Age Groups |
Age Difference |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
All ages | 18-34 | 35-49 | 50-64 | 65+ | |||||||
% | (se) | % | (se) | % | (se) | % | (se) | % | (se) | χ23 | |
I. Total | |||||||||||
30-day | 3.1 | (0.2) | 3.7 | (0.3) | 3.7 | (0.3) | 3.0 | (0.4) | 1.0 | (0.3) | 46.9* |
12-month | 8.3 | (0.3) | 10.4 | (0.5) | 9.4 | (0.5) | 7.7 | (0.7) | 2.6 | (0.4) | 103.5* |
Lifetime | 19.2 | (0.5) | 19.4 | (0.8) | 22.7 | (0.9) | 20.7 | (1.2) | 9.8 | (0.9) | 70.4* |
(n) | (9,282) | (3,033) | (2,865) | (1,922) | (1,461) | ||||||
II. Females | |||||||||||
30-day | 3.9 | (0.2) | 5.0 | (0.5) | 4.5 | (0.4) | 3.3 | (0.5) | 1.5 | (0.5) | 24.1* |
12-month | 10.2 | (0.5) | 13.6 | (0.8) | 11.3 | (0.6) | 9.1 | (1.0) | 3.7 | (0.7) | 63.3* |
Lifetime | 22.9 | (0.6) | 23.7 | (1.1) | 26.7 | (1.0) | 24.6 | (1.5) | 13.0 | (1.3) | 40.8* |
(n) | (5,143) | (1,658) | (1,522) | (1,068) | (894) | ||||||
III. Males | |||||||||||
30-day | 2.3 | (0.2) | 2.4 | (0.4) | 2.9 | (0.5) | 2.8 | (0.5) | 0.2 | (0.2) | 49.2* |
12-month | 6.2 | (0.4) | 7.2 | (0.7) | 7.4 | (0.8) | 6.1 | (0.9) | 1.2 | (0.5) | 90.7* |
Lifetime | 15.1 | (0.8) | 15.1 | (1.2) | 18.6 | (1.4) | 16.2 | (1.4) | 5.3 | (1.2) | 132.1* |
(n) | (4139) | (1375) | (1343) | (854) | (567) |